Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
23%(3 trials)

Phase Distribution

Ph not_applicable
3
20%
Ph early_phase_1
1
7%
Ph phase_4
1
7%
Ph phase_1
8
53%

Phase Distribution

9

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
8(61.5%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(13)
Terminated(1)
Other(1)

Detailed Status

Completed13
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 18 (61.5%)
Phase 41 (7.7%)
N/A3 (23.1%)

Trials by Status

completed1387%
unknown17%
withdrawn17%

Recent Activity

0 active trials
Showing 5 of 15
completedphase_1

KF2024#1-trial: Esketamine Interaction Study

NCT06726382
completed

Drug Interaction With Envarsus XR and Grapefruit Juice

NCT03916380
completednot_applicable

Transporter Mediated Uptake of Montelukast

NCT00513760
completedearly_phase_1

CYP3A4 Activity and Mineral Homeostasis

NCT02019875
completedphase_1

Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers

NCT03366974
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06726382Phase 1

KF2024#1-trial: Esketamine Interaction Study

Completed
NCT03916380

Drug Interaction With Envarsus XR and Grapefruit Juice

Completed
NCT00513760Not Applicable

Transporter Mediated Uptake of Montelukast

Completed
NCT02019875Early Phase 1

CYP3A4 Activity and Mineral Homeostasis

Completed
NCT03366974Phase 1

Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers

Completed
NCT02904434

Gastrointestinal Implications of Voriconazole Exposure

Withdrawn
NCT02232269Phase 1

Coffee Interaction With the Antihypertensive Drug Felodipine

Completed
NCT03012763Phase 1

Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums

Completed
NCT02257008Phase 1

Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers

Completed
NCT02187328Not Applicable

Effects of Fruit Juices on Hormone Metabolism

Unknown
NCT00375245Phase 1

Rapamycin With Grapefruit Juice for Advanced Malignancies

Completed
NCT01743300Phase 1

The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients

Completed
NCT00817999Phase 4

The Impact of Grapefruit Juice on the Response to Clopidogrel

Completed
NCT00984009Phase 1

A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice

Completed
NCT01271296Not Applicable

Effects and Interactions of Liquorice and Grapefruit on Glucocorticoid Replacement Therapy in Addison's Disease

Completed

All 15 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
15